Wan Y Lau
Overview
Explore the profile of Wan Y Lau including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
1298
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lei Z, Ma W, Si A, Zhang Y, Yang F, Yu Q, et al.
Aliment Pharmacol Ther
. 2023 Jun;
58(6):611-622.
PMID: 37349908
Background: Immune checkpoint inhibitor (ICI) combination therapy offers a new option for treatment of unresectable intrahepatic cholangiocarcinoma (uICC). Aim: To compare the effect of different anti-PD-1 combination therapies as the...
2.
Chen Z, Zhang X, Feng J, Li L, Zhang F, Hu Y, et al.
HPB (Oxford)
. 2021 Dec;
24(7):1063-1073.
PMID: 34961677
Background: Microvascular invasion (MVI) is a risk factor of post-hepatectomy tumor recurrence for hepatocellular carcinoma (HCC). The patterns, treatments, and prognosis have not been documented in HCC patients with MVI....
3.
Zhang F, Lu C, Zhang X, Chen Z, Zhong C, Hu Y, et al.
HPB (Oxford)
. 2019 Nov;
22(7):1025-1033.
PMID: 31732465
Background: The aim of this study was to evaluate the effect of portal vein tumor thrombus (PVTT) on the prognosis of patients undergoing liver resection (LR) for primary liver malignancies...
4.
Cheng Z, Lei Z, Si A, Yang P, Luo T, Guo G, et al.
HPB (Oxford)
. 2019 Jul;
21(12):1656-1666.
PMID: 31307889
Background: Several studies have noted that the discriminatory ability and stratification performance of the AJCC 8th edition staging system is not entirely satisfactory. We aimed to improve the American Joint...
5.
Zhang X, Chai Z, Gao Y, Chen Z, Wang K, Shi J, et al.
HPB (Oxford)
. 2019 Jun;
21(12):1687-1696.
PMID: 31153833
Background: Microvascular invasion (MVI) is a major determinant of survival outcome for hepatocellular carcinoma (HCC). This study aimed to investigate the efficacy of postoperative adjuvant Sorafenib (PA-Sorafenib) in HCC patients...
6.
Zhang X, Gao Y, Jiang Y, Wang K, Chen Z, Guo W, et al.
HPB (Oxford)
. 2018 Aug;
21(3):335-344.
PMID: 30104175
Background: Lymph node metastasis (LNM)has widely been recognized as a poor prognostic indicator for hepatocellular carcinoma (HCC) patients. Preoperative prediction of LNM is important for clinicians to decide on treatment....
7.
Li J, Xu X, Han J, Wu H, Xing H, Li C, et al.
HPB (Oxford)
. 2018 Aug;
21(2):157-166.
PMID: 30082212
Background: Serum prealbumin is a sensitive and stable marker for nutritional status and liver function. Whether preoperative prealbumin level is associated with long-term prognosis in patients undergoing liver resection for...
8.
Wang Z, Peng Y, Hu J, Wang X, Sun H, Sun J, et al.
Ann Surg
. 2018 Jul;
271(3):534-541.
PMID: 29995681
Objective: The aim of the study is to assess the efficacy and safety of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) in patients with hepatitis B...
9.
Shen Y, Bai X, Jin G, Zhang Q, Lu J, Qin R, et al.
HPB (Oxford)
. 2018 Jun;
20(11):1034-1043.
PMID: 29929784
Background: Pancreatic head adenocarcinoma is commonly diagnosed at an advanced stage when adjacent vascular invasion is present. This study aimed to establish a preoperative prognostic nomogram for patients who underwent...
10.
Pardo F, Sangro B, Lee R, Manas D, Jeyarajah R, Donckier V, et al.
Ann Surg Oncol
. 2017 Jun;
24(9):2465-2473.
PMID: 28653161
Background: Reports show that selective internal radiation therapy (SIRT) may downsize inoperable liver tumors to resection or transplantation, or enable a bridge-to-transplant. A small-cohort study found that long-term survival in...